Impaired glucose tolerance as a risk factor for stroke in a cohort of non-institutionalised people aged 70 years

Age and Ageing

Volumn 35, Issue 6, 2006, Pages 592-596

  Kaarisalo, Minna M ^a,b   Räihä, Ismo ^a   Arve, Seija ^a   Lehtonen, Aapo ^a  

^a TURKU CITY HOSPITAL   (Finland)

^b NONE   (Finland)

Author keywords

Elderly; Impaired glucose tolerance; Ischaemic stroke; Risk

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

AGED; CEREBROVASCULAR ACCIDENT; FEMALE; GLUCOSE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33750296574     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afl094     Document Type: Article

References (30)

1. Barzilay JI, Spiekerman CF, Wahl PW et al. Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 1999; 354: 622-5.
2. Fuller JH, Shipley MJ, Rose G et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. Br Med J (Clin Res Ed) 1983; 287: 867-70.
3. Burchfiel CM, Curb JD, Rodriguez BL et al. Glucose intolerance and 22-year stroke incidence: The Honolulu Heart Program. Stroke 1994; 25: 951-7.
4. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycaemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998; 21: 1236-9.
5. Balkau B, Shipley M, Jarrett RJ et al. High blood glucose concentration is a risk factor for mortality in middle-aged non-diabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360-7.
6. DECODE Study Group the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
7. Smith NL, Barzilay JI, Shaffer D et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: The Cardiovascular Health Study. Arch Intern Med 2002; 162: 209-16.
8. Mazza A, Pessina AC, Pavei A et al. Predictors of stroke mortality in elderly people from the general population. The Cardiovascular Study Elderly. Eur J Epidemiol 2001; 17: 1097-104.
9. Ohlson LO, Bjuro T, Larsson B et al. A cross-sectional analysis of glucose tolerance and cardiovascular disease in 67-year old men. Diabet Med 1989; 6: 112-20.
10. Mykkanen L, Laakso M, Pyorala K. Asymptomatic hyperglycemia and atherosclerotic vascular disease in the elderly. Diabetes Care 1992; 15: 1020-30.
11. Qureshi AI, Giles WH, Croft JB. Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: The Third National Health and Nutrition Examination Survey. Stroke 1998; 29: 1329-32.
12. WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I. Diagnosis and classification of diabetes mellitus. Report no. 99.2, Geneva, World Health Organization, 1999.
13. Sarti C. Epidemiology of Stroke in Finnish Adult Population: The FINMONICA Stroke Register. Incidence, Mortality and Case-fatality Rates of Strokes and their Trends from 1983 to 1989. Dissertation. Publications of the National Health Institute, Helsinki, 1994.
14. Tuomilehto J, Rastenyte D, Sivenius J et al. Ten year trends in stroke incidence and mortality in the FINMONICA Stroke Study. Stroke 1996; 27: 825-32.
15. Sivenius J, Tuomilehto J, Immonen-Räihä P et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: The FINSTROKE Study. Stroke 2004; 35: 420-5.
16. Abbott RD, Donahue RP, McMahon SW et al. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987; 257: 949-52.
17. SAS Institute Inc. SAS/Stat Users Guide, Version 6, Vol. 1 and 2, 4th edition. Cary, NC: SAS Institute Inc, 1990.
18. Agner E, Thorsteinsson B, Eriksen M. Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care 1982; 5: 600-4.
19. Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-24.
20. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 61-9.
21. Harris MI. Impaired glucose tolerance-prevalence and conversion to NIDDM. Diabet Med 1996; 13 (Suppl. 2): S9-S12.
22. Sprafka JM, Virnig BA, Shahar E et al. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: The Minnesota Heart Survey. Diabetic Med 1994; 11: 678-84.
23. Lam KS, Ma JT, Woo E et al. High prevalence of undiagnosed diabetes among Chinese patients with ischaemic stroke. Diabetes Res Clin Pract 1991; 14: 133-7.
24. Curb JD, Rodriguez BL, Burchfiel CM et al. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 1995; 91: 2591-5.
25. Ford ES, DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes: Findings from the National Health and Nutrition Examination Survey I: Epidemiologic follow-up study. Am J Epidemiol 1991; 133: 1220-30.
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26 (Suppl. 1): S5-20.
27. Mahonen M, Salomaa V, Keskimaki I et al. The feasibility of combining data from routine Hospital Discharge and Causes-of-Death Registers for epidemiological studies on stroke. Eur J Epidemiol 2000; 16: 815-7.
28. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA 1991; 265: 3255-3264.
29. Slovick DI, Amery A, Birkenhager W et al. SYST-EUR multicentre trial on the treatment of isolated systolic hypertension in the elderly: First interim report. J Hum Hypertens 1993; 7: 201-3.
30. Sprafka JM, Burke GL, Folsom AR et al. Continued decline in cardiovascular disease risk factors: Results from the Minnesota Heart Survey, 1980-82 to 1985-87. Am J Epidemiol 1990; 132: 489-500.